Table 1.
Sample characteristics. Standard deviation is noted between brackets. UPDRS: Unified Parkinson Disease Rating Scale; LEDD: levodopa equivalent daily dose; M: male; F: female.
| Healthy controls |
All patients |
L-DOPA only |
DA agonist only |
Dual- therapy |
|
|---|---|---|---|---|---|
| Sample size | 31 | 63 | 26 | 14 | 23 |
| Age (years) | 63,9 (5,1) | 63,7 (7,9) | 65,5 (9,0) | 62,8 (7,2) | 62,4 (7,0) |
| Sex (M:F) | 16:15 | 44:19 | 20:6 | 8:6 | 16:7 |
| Education (years) | 16,7 (2,5) | 15,7 (2,5) | 16,0 (2,4) | 16,1 (2,5) | 15,0 (2,5) |
| Disease duration (years) |
- | 6,4 (4,8) | 5,0 (2,5) | 6,0 (7,7) | 8,3 (4,0) |
| UPDRS motor score (OFF medication) |
- | 26,4 (13,0) | 24,4 (10,3) | 23,4 (10,8) | 30,4 (16,1) |
| Total LEDD (mg) | - | 717,5 (440) | 745,6 (429) | 242,9 (107) | 974,7 (342) |